|
|
Volumn 18, Issue 1, 2011, Pages 12-15
|
|
Cancer genome explosion and systems biology: Impact on surgical oncology?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERLOTINIB;
GEFITINIB;
MONOCLONAL ANTIBODY;
PANITUMUMAB;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN TYROSINE KINASE INHIBITOR;
TRASTUZUMAB;
VASCULOTROPIN;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GENETICS;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER SCREENING;
CANCER STAGING;
CANCER SURGERY;
CANCER THERAPY;
CARCINOGENESIS;
COLON CANCER;
COLONOSCOPY;
COLORECTAL CANCER;
COMPARATIVE EFFECTIVENESS;
DNA SEQUENCE;
DRUG EFFICACY;
DRUG TARGETING;
ENVIRONMENTAL FACTOR;
GENE INTERACTION;
GENE MUTATION;
GENE SEQUENCE;
GENOTYPE PHENOTYPE CORRELATION;
HEREDITY;
HUMAN;
HUMAN GENOME;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
LYMPH NODE METASTASIS;
MAMMOGRAPHY;
MELANOMA;
METASTASIS;
MINIMAL RESIDUAL DISEASE;
MOLECULAR EVOLUTION;
OVERALL SURVIVAL;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SIGNAL TRANSDUCTION;
SOLID TUMOR;
STOMACH CANCER;
SYSTEMS BIOLOGY;
TUMOR VASCULARIZATION;
GENERAL SURGERY;
GENOME, HUMAN;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
SYSTEMS BIOLOGY;
|
|
EID: 78651377238
PISSN: 10689265
EISSN: 15344681
Source Type: Journal
DOI: 10.1245/s10434-010-1355-y Document Type: Review |
|
Times cited : (91)
|
|
References (10)
|
